171596-29-5

  • Product Name:Tadalafil
  • Molecular Formula:C22H19N3O4
  • Purity:99%
  • Molecular Weight:
Inquiry

Product Details

Appearance:white powder

Throughput:10000|Kilogram|Year

pd_productuse: Male Sex Hormones

Delivery Time:3days

Shanghai Upbio Tech Co.,Ltd is a good supplier of Tadalafil . You can buy high quality, Tadalafil 171596-29-5 Tadalafil In Medicine here. 

High Quality Raw materials of health products Tadalafil 171596-29-5 In Medicine Good Supplier

  • Molecular Formula:C22H19N3O4
  • Molecular Weight:389.411
  • Appearance/Colour:white to off-white cyrstalline solid 
  • Vapor Pressure:5.29E-13mmHg at 25°C 
  • Melting Point:298-300 °C 
  • Refractive Index:1.705 
  • Boiling Point:679.1 °C at 760 mmHg 
  • PKA:16.68±0.40(Predicted) 
  • Flash Point:364.5 °C 
  • PSA:74.87000 
  • Density:1.51 g/cm3 
  • LogP:2.08710 

Tadalafil 171596-29-5 Usage

Tadalafil (TDF) was originally developed as a treatment for erectile dysfunction in addition to other PDE5 inhibitors: sildenafil, vardenafil, and avanafil. The chemical formula of Tadalafil is C22H19N3O4 which containing 22 Carbon atoms,19 Hydrogen atoms,3 Nitrogen atoms and 4 Oxygen atoms,and the molecular weight of Tadalafil is 389.411.

Tadalafil is a highly selective inhibitor of PDE5A, it prevented glomerular injury in a rat model of kidney injury.

InChI:InChI=1/C22H23N3O3/c1-24-8-9-25-17(22(24)26)11-15-14-4-2-3-5-16(14)23-20(15)21(25)13-6-7-18-19(10-13)28-12-27-18/h2-7,10,15,17,20-21,23H,8-9,11-12H2,1H3/t15?,17-,20?,21-/m1/s1

171596-29-5 Relevant articles

Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools

Ahmed K. Kammoun, Maan T. Khayata, Ahmad J. Almalkia and Rasha M. Youssef

RSC Adv., 2023, 13, 11817-11825

Pharmaceutical grade of Finasteride and Tadalafil were supplied from Sigma-Aldrich (GmbH, Steinheim, Germany). The main advantage of the proposed derivative spectrophotometric method in comparison with the reported method is the greenness as it used ethanol instead of methanol.

Efficacy of tadalafil and l-arginine combination therapy compared with tadalafil-only for the treatment of erectile dysfunction: A systematic review and meta-analysis

Donny Austine Wibisono ,  Furqan Hidayatullah ,  Fikri Rizaldi ,  Tarmono Djojodimedjo

Paragraph 0015; 0041-0042, (2022/03/27)

The combination of tadalafil and L-arginine can improve erectile function and testosterone levels. A significant increase in IIEF-5 score and testosterone level is observed in patients with ED who received combination therapy of tadalafil and L-arginine compared to tadalafil monotherapy.

171596-29-5 Process route

(6R,12aR)-6-(3,4-dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2'-1,6]-pyrido[3,4-b]indole-1,4-dione
171489-03-5

(6R,12aR)-6-(3,4-dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2'-1,6]-pyrido[3,4-b]indole-1,4-dione

1,1-dibromomethane
74-95-3

1,1-dibromomethane

(6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione
171596-29-5

(6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione

Conditions
Conditions Yield
With sodium hydroxide; In N,N-dimethyl-formamide; at 60 ℃; for 6h;
95%
With caesium carbonate; In N,N-dimethyl-formamide; at 80 ℃; for 8h;
93%
With caesium carbonate; In N,N-dimethyl-formamide; at 80 ℃; for 8h;
93%
With caesium carbonate; In N,N-dimethyl-formamide; at 80 ℃; for 8h;
93%
(1R,3R)-methyl-1,2,3,4-tetrahydro-2-(2-(benzyl(methyl)amino)acetyl)-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate
1224724-00-8

(1R,3R)-methyl-1,2,3,4-tetrahydro-2-(2-(benzyl(methyl)amino)acetyl)-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate

(6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione
171596-29-5

(6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione

Conditions
Conditions Yield
With hydrogen; Raney Ni; In ISOPROPYLAMIDE; at 80 ℃; for 22h; under 2280.15 Torr; Product distribution / selectivity;
94%

171596-29-5 Upstream products

  • 74-89-5
    74-89-5

    methylamine

  • 171489-59-1
    171489-59-1

    methyl (1R,3R)-1-(3,4-methylenedioxyphenyl)-2-chloroacetyl-2,3,4,9-tetrahydro-9H-pyrido[3,4-b]indol-3-carboxylate

  • 749864-18-4
    749864-18-4

    1-benzo[1,3]dioxol-5-yl-2-{[(9H-fluoren-9-ylmethoxycarbonyl)-methyl-amino]-acetyl}-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid methyl ester

  • 951661-81-7
    951661-81-7

    (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide

171596-29-5 Downstream products

  • 171596-27-3
    171596-27-3

    (6R,12aS)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione

  • 1220393-12-3
    1220393-12-3

    3-((2-(benzo[d][1,3]dioxole-5-carbonyl)-1H-indol-3-yl)methyl)-1-methylpiperazine-2,5-dione

  • 1242099-13-3
    1242099-13-3

    C10H12O3*C22H19N3O4

  • 1242099-11-1
    1242099-11-1

    C8H8O3*C22H19N3O4

Relevant Products